|
1
|
Jemal A, Siegel R, Ward E, et al: Cancer
statistics, 2009. CA Cancer J Clin. 59:225–249. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Motzer RJ, Hutson TE, Tomczak P, et al:
Overall survival and updated results for sunitinib compared with
interferon alfa in patients with metastatic renal cell carcinoma. J
Clin Oncol. 27:3584–3590. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao Q, Wang J, Zhang M, et al: Genetic
Variants in RKIP Are Associated with Clear Cell Renal Cell
Carcinoma Risk in a Chinese Population. PLoS One. 9:e1092852014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mu HJ, Zou J, Xie P, Xu ZQ, Ruan J, Yang
SD and Yin Y: Association of leptin receptor Lys109Arg and
Gln223Arg polymorphisms with increased risk of clear cell renal
cell carcinoma. Asian Pac J Cancer Prev. 15:4211–4215. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Patard JJ, Pouessel D, Bensalah K and
Culine S: Targeted therapy in renal cell carcinoma. World J Urol.
26:135–140. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Motzer RJ, Hutson TE, Tomczak P, et al:
Sunitinib versus interferon alfa in metastatic renal-cell
carcinoma. N Engl J Med. 356:115–124. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vincenti V, Cassano C, Rocchi M and
Persico G: Assignment of the vascular endothelial growth factor
gene to human chromosome 6p21.3. Circulation. 93:1493–1495. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Watson CJ, Webb NJ, Bottomley MJ and
Brenchley PE: Identification of polymorphisms within the vascular
endothelial growth factor (VEGF) gene: correlation with variation
in VEGF protein production. Cytokine. 12:1232–1235. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Koukourakis MI, Papazoglou D,
Giatromanolaki A, et al: VEGF gene sequence variation defines VEGF
gene expression status and angiogenic activity in non-small cell
lung cancer. Lung Cancer. 46:293–298. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Luo T, Chen L, He P, et al: Vascular
endothelial growth factor (VEGF) gene polymorphisms and breast
cancer risk in a Chinese population. Asian Pac J Cancer Prev.
14:2433–2437. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sivaprasad S, Govardhan B, Harithakrishna
R, et al: Association of vascular endothelial growth factor (VEGF)
gene polymorphism and increased serum VEGF concentration with
pancreatic adenocarcinoma. Pancreatology. 13:267–272. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mandal RK, Yadav SS, Panda AK and Khattri
S: Vascular endothelial growth factor 936 c>T polymorphism
increased oral cancer risk: evidence from a meta-analysis. Genet
Test Mol Biomarkers. 17:543–547. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
He D, Lu W, Chang K, et al: Vascular
endothelial growth factor polymorphisms and risk of Alzheimer’s
disease: a meta-analysis. Gene. 518:296–302. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Garcia-Donas J, Rodriguez-Antona C and
Jonasch E: Molecular markers to predict response to therapy. Semin
Oncol. 40:444–458. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vrdoljak E, Rini B, Schmidinger M, et al:
Bisphosphonates and vascular endothelial growth factor-targeted
drugs in the treatment of patients with renal cell carcinoma
metastatic to bone. Anticancer Drugs. 24:431–440. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jäkel CE, Hauser S, Rogenhofer S, et al:
Clinical studies applying cytokine-induced killer cells for the
treatment of renal cell carcinoma. Clin Dev Immunol.
2012:4732452012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kawai Y, Sakano S, Korenaga Y, Eguchi S
and Naito K: Associations of single nucleotide polymorphisms in the
vascular endothelial growth factor gene with the characteristics
and prognosis of renal cell carcinomas. Eur Urol. 52:1147–1155.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sáenz-López P, Vazquez F, Cozar JM, et al:
VEGF polymorphisms are not associated with an increased risk of
developing renal cell carcinoma in Spanish population. Hum Immunol.
74:98–103. 2013. View Article : Google Scholar
|
|
20
|
Edge SB, Byrd DR, Compton CC, et al:
Kidney. AJCC Cancer Staging Manual. 7th edition. Springer; New
York, NY: pp. 2010479–2010489. 2010
|
|
21
|
Abe A, Sato K, Habuchi T, et al: Single
nucleotide polymorphisms in the 3′ untranslated region of vascular
endothelial growth factor gene in Japanese population with or
without renal cell carcinoma. Tohoku J Exp Med. 198:181–190. 2002.
View Article : Google Scholar
|
|
22
|
Salven P, Teerenhovi L and Joensuu H: A
high pretreatment serum vascular endothelial growth factor
concentration is associated with poor outcome in non-Hodgkin’s
lymphoma. Blood. 90:3167–3172. 1997.PubMed/NCBI
|
|
23
|
Martinez-Fierro ML, Garza-Veloz I,
Rojas-Martinez A, et al: Positive association between vascular
endothelial growth factor (VEGF) −2578 C/A variant and prostate
cancer. Cancer Biomark. 13:235–241. 2013.
|
|
24
|
Chen P, Zhu J, Liu DY, et al:
Over-expression of survivin and VEGF in small-cell lung cancer may
predict the poorer prognosis. Med Oncol. 31:7752014. View Article : Google Scholar
|
|
25
|
Oh SY, Kwon HC, Kim SH, et al: The
relationship of vascular endothelial growth factor gene
polymorphisms and clinical outcome in advanced gastric cancer
patients treated with FOLFOX: VEGF polymorphism in gastric cancer.
BMC Cancer. 13:432013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Absenger G, Szkandera J, Stotz M, et al: A
common and functional gene variant in the vascular endothelial
growth factor a predicts clinical outcome in early-stage breast
cancer. Mol Carcinog. 52(Suppl 1): E96–E102. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hefler LA, Mustea A, Könsgen D, et al:
Vascular endothelial growth factor gene polymorphisms are
associated with prognosis in ovarian cancer. Clin Cancer Res.
13:898–901. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Shahbazi M, Fryer AA, Pravica V, et al:
Vascular endothelial growth factor gene polymorphisms are
associated with acute renal allograft rejection. J Am Soc Nephrol.
13:260–264. 2002.
|
|
29
|
Sa-Nguanraksa D, Chuangsuwanich T,
Pongpruttipan T, et al: Vascular endothelial growth factor −634G/C
polymorphism is associated with increased breast cancer risk and
aggressiveness. Mol Med Rep. 8:1242–1250. 2013.PubMed/NCBI
|
|
30
|
Supic G, Jovic N, Zeljic K, Kozomara R and
Magic Z: Association of VEGF-A genetic polymorphisms with cancer
risk and survival in advanced-stage oral squamous cell carcinoma
patients. Oral Oncol. 48:1171–1177. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jin Q, Hemminki K, Enquist K, et al:
Vascular endothelial growth factor polymorphisms in relation to
breast cancer development and prognosis. Clin Cancer Res.
11:3647–3653. 2005. View Article : Google Scholar : PubMed/NCBI
|
